Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vogl

Showing results (261-270 of 342) with videos related to

Pageof 35
Sort By:
Osteoarthritis and Cartilage|June 15, 2014
Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levelsR F Schelbergen, S van Dalen, M ter Huurne, et al.
The Journal of Biological Chemistry|July 21, 2001
The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genesI S Thorey, J Roth, J Regenbogen, et al.
Blood Advances|December 12, 2025
Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple MyelomaHeta Patel, Harper Hubbeling, Kyle L Yu, et al.
Kidney International|May 16, 2018
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin depositsRamnika Gumber, Jordana B Cohen, Matthew B Palmer, et al.
Geburtshilfe Und Frauenheilkunde|January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Cancer Research Communications|March 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of MegakaryocytesCindy Lin, Laura Garcia-Gerique, Erin E Bonner, et al.
Blood|September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myelomaJatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Blood Cancer Journal|November 4, 2025
Outcomes of relapse after teclistamab therapy in multiple myelomaKyle L Yu, Matthew Ho, Luca Paruzzo, et al.
British Journal of Haematology|March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapyLuca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Pageof 35

Showing results (261-270 of 342) with videos related to

Sort By:
Pageof 35
Osteoarthritis and Cartilage|June 15, 2014
Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levelsR F Schelbergen, S van Dalen, M ter Huurne, et al.
The Journal of Biological Chemistry|July 21, 2001
The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genesI S Thorey, J Roth, J Regenbogen, et al.
Blood Advances|December 12, 2025
Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple MyelomaHeta Patel, Harper Hubbeling, Kyle L Yu, et al.
Kidney International|May 16, 2018
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin depositsRamnika Gumber, Jordana B Cohen, Matthew B Palmer, et al.
Geburtshilfe Und Frauenheilkunde|January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Cancer Research Communications|March 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of MegakaryocytesCindy Lin, Laura Garcia-Gerique, Erin E Bonner, et al.
Blood|September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myelomaJatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Blood Cancer Journal|November 4, 2025
Outcomes of relapse after teclistamab therapy in multiple myelomaKyle L Yu, Matthew Ho, Luca Paruzzo, et al.
British Journal of Haematology|March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapyLuca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Pageof 35